Compare HROW & STRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HROW | STRA |
|---|---|---|
| Founded | 1998 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | N/A | 1996 |
| Metric | HROW | STRA |
|---|---|---|
| Price | $52.18 | $75.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | $68.86 | ★ $96.50 |
| AVG Volume (30 Days) | ★ 474.2K | 186.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.16% |
| EPS Growth | N/A | ★ 60.48 |
| EPS | N/A | ★ 3.76 |
| Revenue | N/A | ★ $997,137,000.00 |
| Revenue This Year | $38.82 | $5.99 |
| Revenue Next Year | $42.18 | $3.79 |
| P/E Ratio | ★ N/A | $20.24 |
| Revenue Growth | N/A | ★ 57.23 |
| 52 Week Low | $20.85 | $72.17 |
| 52 Week High | $54.98 | $102.54 |
| Indicator | HROW | STRA |
|---|---|---|
| Relative Strength Index (RSI) | 60.16 | 40.48 |
| Support Level | $48.73 | $75.25 |
| Resistance Level | $50.98 | $77.36 |
| Average True Range (ATR) | 2.38 | 3.11 |
| MACD | 0.55 | -0.57 |
| Stochastic Oscillator | 93.54 | 30.67 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.